Journal
EXPERT REVIEW OF VACCINES
Volume 8, Issue 10, Pages 1351-1364Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1586/ERV.09.78
Keywords
immunization program; infant; pneumococcal conjugate vaccine; prevention
Categories
Ask authors/readers for more resources
In 2000/2001, a 7-valent pneumococcal conjugate vaccine (PCV-7) was licensed in Europe. During the following years and based on positive experiences from the USA, more and more European countries recommended routine immunization of infants and of children at an increased risk for invasive pneumococcal disease. Many studies documented the impact on invasive pneumococcal disease, but also on noninvasive pneumococcal disease. This review summarizes current evidence on the population-based impact of infant immunization programs in Europe.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available